These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1464019)
1. [Effectiveness of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity]. Poruban D; Koza I; Mracna J; Nagy V; Vasko J Bratisl Lek Listy; 1992 Aug; 93(8):395-400. PubMed ID: 1464019 [TBL] [Abstract][Full Text] [Related]
2. [Toxicity of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity]. Poruban D; Koza I; Mracna J; Nagy V; Vasko J Bratisl Lek Listy; 1989 May; 90(5):339-44. PubMed ID: 2758335 [TBL] [Abstract][Full Text] [Related]
3. High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin. Lin JC; Jan JS; Hsu CY; Wong DY Cancer; 1999 Apr; 85(7):1430-8. PubMed ID: 10193931 [TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study. Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J Oncology; 2002; 63(4):338-45. PubMed ID: 12417788 [TBL] [Abstract][Full Text] [Related]
5. [The clinical effect of cisplatin and 5-FU infusion in oral cancer]. Okutomi T; Ichihara H; Okuda T; Okumura Y; Hyoudou I; Tatematsu N; Oka N Gan To Kagaku Ryoho; 1992 Jul; 19(7):1059-62. PubMed ID: 1626942 [TBL] [Abstract][Full Text] [Related]
6. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma. Perrone F; Bossi P; Cortelazzi B; Locati L; Quattrone P; Pierotti MA; Pilotti S; Licitra L J Clin Oncol; 2010 Feb; 28(5):761-6. PubMed ID: 20048189 [TBL] [Abstract][Full Text] [Related]
7. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results. Kovács AF; Ghahremani MT; Stefenelli U; Bitter K J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943 [TBL] [Abstract][Full Text] [Related]
8. [Long-term intravenous infusion of 5-fluorouracil combined with platidiam in local spread of squamous cell carcinoma of the oral cavity]. Gorbunova VA; Liubaev VL; Shatikhin VA; Brzhezovskiĭ VZh; Pustynskiĭ IN Sov Med; 1989; (5):92-4. PubMed ID: 2675338 [No Abstract] [Full Text] [Related]
9. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer]. Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study. Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572 [TBL] [Abstract][Full Text] [Related]
11. Cisplatin and 5-fluorouracil as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer. Wang HM; Wang CH; Chen JS; Chang HK; Kiu MC; Liaw CC; Ng KT; Lai GM J Formos Med Assoc; 1995 Mar; 94(3):87-94. PubMed ID: 7613250 [TBL] [Abstract][Full Text] [Related]
12. Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU). Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shigeta T; Shibuya Y; Yokoo S; Komori T Kobe J Med Sci; 2004; 50(5-6):189-96. PubMed ID: 16107776 [TBL] [Abstract][Full Text] [Related]
13. Intraarterial chemotherapy as neoadjuvant treatment of oral cancer. Kovács AF; Turowski B; Ghahremani MT; Loitz M J Craniomaxillofac Surg; 1999 Oct; 27(5):302-7. PubMed ID: 10717833 [TBL] [Abstract][Full Text] [Related]
14. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center. Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100 [TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with nedaplatin and 5-fluorouracil for oral squamous cell carcinomas]. Yamaoka K; Fukuda M; Kuwajima S; Hagiwara H; Toshima S; Matsuoka A; Ohnuki T; Seki H; Nagai H; Iino M; Sageshima M Gan To Kagaku Ryoho; 2003 Jul; 30(7):951-5. PubMed ID: 12894709 [TBL] [Abstract][Full Text] [Related]
16. [Low-dose CDDP and 5-FU for head and neck cancer patients]. Fujii M; Kanke M; Tomita T Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma. Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419 [TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer]. Yamshita Y; Shikimori M; Goto M Gan To Kagaku Ryoho; 2005 Sep; 32(9):1267-71. PubMed ID: 16184922 [TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant radiochemotherapy for squamous cell carcinoma of the oral cavity]. Bootz F HNO; 2008 Feb; 56(2):183-4. PubMed ID: 18231725 [No Abstract] [Full Text] [Related]
20. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]